Evidence map›Paper›PMID 24952462›Full record

ArticleNature cell biology2014

The transcription factor GATA6 enables self-renewal of colon adenoma stem cells by repressing BMP gene expression.

Gavin Whissell, Elisa Montagni, Paola Martinelli, Xavier Hernando-Momblona, Marta Sevillano, Peter Jung, Carme Cortina, Alexandre Calon, Anna Abuli, Antoni Castells and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature cell biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 127 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Wnt signaling and tumors (Review).Molecular and clinical oncology · 2024
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. TCF7L1 RegulatesGenes · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 1 country.

Gavin WhissellInstitute for Research in Biomedicine (IRB Barcelona), 08028 Barcelona, Spain.
Elisa Montagni1] Institute for Research in Biomedicine (IRB Barcelona), 08028 Barcelona, Spain [2].
Paola Martinelli1] Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain [2].
Xavier Hernando-MomblonaInstitute for Research in Biomedicine (IRB Barcelona), 08028 Barcelona, Spain.
Marta SevillanoInstitute for Research in Biomedicine (IRB Barcelona), 08028 Barcelona, Spain.
Peter JungInstitute for Research in Biomedicine (IRB Barcelona), 08028 Barcelona, Spain.
Carme CortinaInstitute for Research in Biomedicine (IRB Barcelona), 08028 Barcelona, Spain.
Alexandre CalonInstitute for Research in Biomedicine (IRB Barcelona), 08028 Barcelona, Spain.
Anna Abuli1] Department of Gastroenterology, Hospital Clínic, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, 08036 Barcelona, Catalonia, Spain [2] Department of Gastroenterology, Hospital del Mar-IMIM (Hospital del Mar Medical Research Centre), Pompeu Fabra University, 08003 Barcelona, Catalonia, Spain.
Antoni CastellsDepartment of Gastroenterology, Hospital Clínic, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, 08036 Barcelona, Catalonia, Spain.
Sergi Castellvi-BelDepartment of Gastroenterology, Hospital Clínic, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, 08036 Barcelona, Catalonia, Spain.
Ana Silvina NachtCentre de Regulació Genòmica (CRG), Universitat Pompeu Fabra (UPF), E-08003 Barcelona, Spain.
Elena SanchoInstitute for Research in Biomedicine (IRB Barcelona), 08028 Barcelona, Spain.
Camille Stephan-Otto AttoliniInstitute for Research in Biomedicine (IRB Barcelona), 08028 Barcelona, Spain.
Guillermo P VicentCentre de Regulació Genòmica (CRG), Universitat Pompeu Fabra (UPF), E-08003 Barcelona, Spain.
Francisco X Real1] Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain [2] Universitat Pompeu Fabra, 08003 Barcelona, Spain.
Eduard Batlle1] Institute for Research in Biomedicine (IRB Barcelona), 08028 Barcelona, Spain [2] Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain.
Institute for Research in Biomedicine · ESPompeu Fabra University · ESSpanish National Cancer Research Centre · ESCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas · ESConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESInstitució Catalana de Recerca i Estudis Avançats · ESMunicipal Institute for Medical Research · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aberrant activation of WNT signalling and loss of BMP signals represent the two main alterations leading to the initiation of colorectal cancer (CRC). Here we screen for genes required for maintaining the tumour stem cell phenotype and identify the zinc-finger transcription factor GATA6 as a key regulator of the WNT and BMP pathways in CRC. GATA6 directly drives the expression of LGR5 in adenoma stem cells whereas it restricts BMP signalling to differentiated tumour cells. Genetic deletion of Gata6 from mouse colon adenomas increases the levels of BMP factors, which signal to block self-renewal of tumour stem cells. In human tumours, GATA6 competes with β-catenin/TCF4 for binding to a distal regulatory region of the BMP4 locus that has been linked to increased susceptibility to development of CRC. Hence, GATA6 creates an environment permissive for CRC initiation by lowering the threshold of BMP signalling required for tumour stem cell expansion.

Indexed as

AdenomaGene Expression Regulation, NeoplasticAnimalsAntineoplastic AgentsBone Morphogenetic Protein ReceptorsCell ProliferationColorectal NeoplasmsFemaleFluorescent Antibody TechniqueGATA6 Transcription FactorHumansMaleMicePyrazolesPyrimidinesStem CellsAntineoplastic AgentsBone Morphogenetic Protein ReceptorsGATA6 Transcription FactorLDN 193189PyrazolesPyrimidinesWnt Proteins

Identifiers

PMID24952462
OpenAlexW2053269399

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.